Listed

Techprecision Corp: Form 10-Q for the period ended Jun 30, 2022

Filed with the SEC on Sep 15, 2022 and accepted by EDGAR at Sep 14, 2022, 18:58 ET.

Share

Management's discussion and analysis

As filed, 38,112 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Statement Regarding Forward Looking Disclosure

The following discussion of our financial condition and results of operations should be read in conjunction with our audited consolidated financial statements and the related notes, which appear elsewhere in this Quarterly Report on Form 10-Q. This Quarterly Report on Form 10-Q, including this section titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” may contain predictive or “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of current or historical fact contained in this quarterly report, including statements that express our intentions, plans, objectives, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events, or conditions are forward-looking statements. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “predict,” “project,” “will,” “should,” “would” and similar expressions, as they relate to us, are intended to identify forward-looking statements.

These forward-looking statements are based on current expectations, estimates and projections made by management about our business, our industry and other conditions affecting our financial condition, results of operations or business prospects. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in, or implied by, the forward-looking statements due to numerous risks and uncertainties. Factors that could cause such outcomes and results to differ include, but are not limited to, risks and uncertainties arising from:

  • our reliance on individual purchase orders, rather than long-term contracts, to generate revenue;
  • our ability to balance the composition of our revenues and effectively control operating expenses;
  • external factors, including the COVID-19 pandemic, Russia’s invasion of Ukraine, high inflation and increasing interest rates, that may be outside of our control;
  • the impacts of the COVID-19 pandemic and government-imposed lockdowns in response thereto;
  • the availability of appropriate financing facilities impacting our operations, financial condition and/or liquidity;
  • our ability to receive contract awards through competitive bidding processes;
  • our ability to maintain standards to enable us to manufacture products to exacting specifications;
  • our ability to enter new markets for our services;
  • our reliance on a small number of customers for a significant percentage of our business;
  • competitive pressures in the markets we serve;
  • changes in the availability or cost of raw materials and energy for our production facilities;
  • restrictions in our ability to operate our business due to our outstanding indebtedness;
  • government regulations and requirements;
  • pricing and business development difficulties;
  • changes in government spending on national defense;
  • our ability to make acquisitions and successfully integrate those acquisitions with our business;
  • our failure to maintain effective internal controls over financial reporting;
  • general industry and market conditions and growth rates;
  • unexpected costs, charges or expenses resulting from the recently completed acquisition of Stadco; and
  • those risks discussed in “Item 1A. Risk Factors” and elsewhere in our Annual Report on Form 10-K, as well as those described in any other filings which we make with the SEC.

Any forward-looking statements speak only as of the date on which they are made, and we undertake no obligation to publicly update or revise any forward-looking statements to reflect events or circumstances that may arise after the date of this Quarterly Report on Form 10-Q, except as required by applicable law. Investors should evaluate any statements made by us in light of these important factors.

Overview

Contract Manufacturing

Through our two wholly-owned subsidiaries, Ranor and Stadco (acquired on August 25, 2021), each of which is a reportable segment, we offer a full range of services required to transform raw materials into precision finished products. Our manufacturing capabilities include fabrication operations (cutting, press and roll forming, assembly, welding, heat treating, blasting, and painting) and machining operations including CNC (computer numerical controlled) horizontal and vertical milling centers. We also provide support services to our manufacturing capabilities: manufacturing engineering (planning, fixture and tooling development, manufacturing), quality control (inspection and testing), materials procurement, production control (scheduling, project management and expediting) and final assembly.

All manufacturing is done in accordance with our written quality assurance program, which meets specific national and international codes, standards, and specifications. The standards used are specific to the customers’ needs, and our manufacturing operations are conducted in accordance with these standards.

Because our revenues are derived from the sale of goods manufactured pursuant to contracts, and we do not sell from inventory, it is necessary for us to constantly seek new contracts. There may be a time lag between our completion of one contract and commencement of work on another contract. During such periods, we may continue to incur overhead expense but with lower revenue resulting in lower operating margins. Furthermore, changes in either the scope of an existing contract or related delivery schedules may impact the revenue we receive under the contract and the allocation of manpower. Although we provide manufacturing services for large governmental programs, we usually do not work directly for the government or its agencies. Rather, we perform our services for large governmental contractors. Our business is dependent in part on the continuation of governmental programs that require our services and products.

Our contracts are generated both through negotiation with the customer and from bids made pursuant to a request for proposal. Our ability to receive contract awards is dependent upon the contracting party’s perception of such factors as our ability to perform on time, our history of performance, including quality, our financial condition and our ability to price our services competitively. Although some of our contracts contemplate the manufacture of one or a limited number of units, we continue to seek more long-term projects with predictable cost structures.

All the Company’s operations, assets, and customers are located in the U.S.

Impact of COVID-19 Pandemic

At the beginning of calendar year 2020, the novel strain of coronavirus known as COVID-19 spread worldwide, including to U.S jurisdictions where the Company does business, and became a global pandemic. The United States Government declared a national emergency and various state governments imposed “lockdown” and “shelter-in-place” orders intended to reduce the spread of COVID-19 that have severely restricted business, social activities and travel. The Governors of the Commonwealth of Massachusetts and state of California, in which jurisdiction the Company’s manufacturing and executive offices are located, issued similar emergency orders in March 2020. Although the emergency order for Massachusetts has expired, the national emergency declaration was renewed on July 15, 2022 and the California emergency order remains in effect. As a designated “COVID-19 Essential Service” we continued our operations throughout the pendency of the orders.

Our production facilities continue to operate as they had prior to the outbreak of the COVID-19 pandemic, other than the implementation of enhanced safety measures intended to prevent the spread of the virus. The remote working arrangements and travel restrictions imposed by applicable governmental authorities have not impaired our ability to maintain operations. Our results of operations and cash flows during the three months ended June 30, 2022, and 2021 were not materially affected by the COVID-19 pandemic.

However, given the speed and frequency of continuously evolving developments with respect to this pandemic, the extent to which COVID-19 may adversely impact our business depends on future developments, which are highly uncertain and unpredictable, including new information concerning the severity of the outbreak and the effectiveness of actions globally to contain or mitigate its effects, we cannot reasonably estimate the magnitude of future impact on our financial condition and results of operations.

Critical Accounting Policies and Estimates

The preparation of the condensed consolidated financial statements requires that we make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. We base our estimates on historical experience and various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. We continually evaluate our estimates, including those related to revenue recognition and income taxes. These estimates and assumptions require management’s most difficult, subjective or complex judgments. Actual results may vary under different assumptions or conditions.

We consider the principles and estimates applied for revenue recognition to be one of the most critical accounting estimates that we make. Our revenue can fluctuate from quarter-to-quarter as we measure revenue recognition over the duration of a project, or at the end of the project. The Company records most of its revenue over time as it completes performance obligations or at a point-in-time, for example, at the delivery date, when control of the promised goods are transferred to the customer. Project volume for revenue recognized at a point-in-time is generally smaller, can fluctuate from period to period, and is difficult to forecast.

We measure progress for performance obligations satisfied over time using input methods, for example, labor hours expended and time elapsed. As a result, assuming a steady flow of project volume and labor hours, we have the ability to deliver a fair and accurate flow of revenue over time. When project volume is higher or lower, we may report higher or lower amounts of revenue for those given quarterly periods.

Our significant accounting policies are set forth in detail in Note 2 to the consolidated financial statements included in the 2022 Annual Report on Form 10-K. There were no significant changes to our critical accounting policies during the nine months ended June 30, 2022.

New Accounting Standards

See Note 17, Accounting Standards Update, in the Notes to the Unaudited Condensed Consolidated Financial Statements under “Item 1. Financial Statements”, for a discussion of recently adopted new accounting guidance and new accounting guidance not yet adopted.

Results of Operations

Our results of operations are affected by a number of external factors including the availability of raw materials, commodity prices (particularly steel), macroeconomic factors, including the availability of capital that may be needed by our customers, and political, regulatory and legal conditions in the United States and in foreign markets. It generally takes approximately twelve months or less to complete our manufacturing projects. However, contracts for larger complex components can take up to thirty-six months to complete. Units manufactured under the majority of our customer contracts have historically been delivered on time and with a positive gross margin, with some exceptions. Our results of operations are also affected by our success in booking new contracts, the timing of revenue recognition, delays in customer acceptances of our products, delays in deliveries of ordered products and our rate of progress fulfilling obligations under our contracts. A delay in deliveries or cancellations of orders could have an unfavorable impact on liquidity, cause us to have inventories in excess of our short-term needs, and delay our ability to recognize, or prevent us from recognizing, revenue on contracts in our order backlog.

We evaluate the performance of our segments based upon, among other things, segment net sales and operating profit. Segment operating profit excludes general corporate costs, which include executive and director compensation, stock-based compensation, certain pension and other retirement benefit costs, and other corporate facilities and administrative expenses not allocated to the segments. Also excluded are items that we consider not representative of ongoing operations, such as the unallocated PPP loan forgiveness.

Key Performance Indicators

While we prepare our financial statements in accordance with U.S. generally accepted accounting principles, or “U.S. GAAP”, we also utilize and present certain financial measures that are not based on or included in U.S. GAAP. We refer to these as non-GAAP financial measures. Please see the section titled “EBITDA Non-GAAP financial measure” below for further discussion of these financial measures, including the reasons why we use such financial measures and reconciliations of such financial measures to the most directly comparable U.S. GAAP financial measures.

Percentages in the following tables and throughout this “Results of Operations” section may reflect rounding adjustments.

Three Months Ended June 30, 2022 and 2021

The following table presents net sales, gross profit and gross margin, consolidated and by reportable segment:

(dollars in thousands)

​ ​ ​ ​ ​ ​ ​ ​ June 30, 2022 ​ ​ Amount ​ ​ ​ ​ ​ Percent of ​ Net sales ​ ​ June 30, 2021 ​ ​ Amount ​ ​ ​ ​ ​ Percent of ​ Net sales ​ ​ Changes ​ ​ Amount ​ ​ ​ ​ ​ Percent of ​ Net sales ​
Ranor $4,726 67% $3,412 100% $1,314 ​ 39%
Stadco ​ 2,350 33% — —% 2,350 ​ nm%
Net sales ​ $7,076 100% $3,412 100% $3,664 ​ 107%
Ranor ​ $2,886 41% $2,579 76% $307 ​ 12%
Stadco ​ 3,373 48% — —% 3,373 ​ nm%
Cost of sales ​ $6,259 89% $2,579 76% $3,680 ​ 143%
Ranor ​ $1,840 26% $833 24% $1,007 ​ 121%
Stadco ​ (1,023) (14)% — —% (1,023) ​ nm%
Gross profit ​ $817 12% $833 24% $(16) ​ (2)%

nm - not meaningful

Net Sales

Consolidated - Net sales were $7.1 million or $3.7 million higher when compared to consolidated net sales for the three months ended June 30, 2021. Net sales in defense markets increased by $3.7 million, due primarily to the new revenue from our Stadco segment, which made up $2.2 million of the increase. Net sales to precision industrial markets decreased by less than $0.1 million.

Ranor - Net sales were $4.7 million for the three months ended June 30, 2022, or $1.3 million and 39% higher when compared to the same prior year period. Net sales increased year over year primarily on new orders of repeat components. Net sales to defense customers increased by $1.5 million. The defense backlog for Ranor remains strong as new orders for components related to a variety of programs continue to flow down from our existing customer base of prime defense contractors. Net sales to precision industrial markets decreased by $0.2 million due to lower project activity. We have repeat business in this sector, but the order flow can be uneven and difficult to forecast.

Stadco - Net sales were $2.4 million for the three months ended June 30, 2022, with $2.2 million and $0.2 million completed for customers in the defense and precision industrial markets, respectively. Our defense backlog for Stadco is strong as new orders for components related to a variety of programs, including components for heavy lift helicopters.

Gross Profit and Gross Margin

Consolidated - Cost of sales consists primarily of raw materials, parts, labor, overhead and subcontracting costs. Our cost of sales for the three months ended June 30, 2022 was $3.7 million higher when compared to the three months ended June 30, 2021. The increase in cost of sales and lower gross margin was primarily the result of an unfavorable production mix and under-absorbed factory overhead at our Stadco segment. As a result, gross profit was $0.8 million, or 2% lower when compared to the three months ended June 30, 2021. Gross margin was 11.6% for the three months ended June 30, 2022 compared to 24.4% for the three months ended June 30, 2021.

Ranor - The gross profit and gross margin significantly increased year over year with improved throughput on new orders of repeat components. This set of favorable conditions, accelerating project progress and better overhead absorption rates on higher revenue recognized over-time, began to take hold in the fourth quarter of fiscal 2022. We expect this trend to continue in fiscal 2023.

Stadco - The gross margin turned negative at the end of fiscal year 2022 and continued through the first quarter of fiscal 2023. New project startups and associated production activities resulted in unfavorable throughput and an increase in under-absorbed overhead. We expect gradual improvements in gross margin for the remainder of fiscal 2023 as the new projects make progress to completion.

Selling, General and Administrative (SG&A) Expenses

(dollars in thousands)

​ ​ ​ ​ ​ ​ ​ ​ June 30, 2022 ​ ​ Amount ​ ​ ​ ​ Percent of ​ Net Sales ​ ​ ​ June 30, 2021 ​ ​ Amount ​ ​ ​ ​ Percent of ​ Net Sales ​ ​ ​ Changes ​ ​ Amount ​ ​ ​ ​ ​ Percent
Ranor ​ $487 7% $405 12% $82 20%
Stadco ​ 436 6% — —% 436 nm%
Corporate and unallocated ​ 452 7% 327 10% 125 38%
Consolidated SG&A ​ $1,375 20% $732 22% $643 88%

nm – not meaningful

Consolidated - Total selling, general and administrative expenses for the three months ended June 30, 2022, increased by $0.6 million, or 88%, as the Company completed its acquisition of Stadco and spending on outside advisory services and business travel returned to pre-pandemic levels.

Ranor – Advisory fees, travel expenses and other office costs increased by approximately $0.1 million due to a return to pre-pandemic travel and business activity.

Stadco - The increase was due to the inclusion of Stadco operations which were not part of the Company in the comparable prior year period. Expenses incurred during the period were slightly below monthly averages.

Corporate and unallocated - Advisory fees, travel expenses and other office costs increased by approximately $0.1 million due to a return to pre-pandemic travel and business activity.

Operating (loss) income

(dollars in thousands)

​ ​ ​ ​ ​ ​ ​ ​ June 30, 2022 ​ ​ Amount ​ ​ ​ ​ Percent of ​ net sales ​ ​ ​ June 30, 2021 ​ ​ Amount ​ ​ ​ ​ Percent of ​ net sales ​ ​ ​ Changes ​ ​ Amount ​ ​ ​ ​ ​ Percent
Ranor ​ $1,353 19% $427 13% $926 217%
Stadco ​ (1,459) (21)% — —% (1,459) nm%
Corporate and unallocated ​ (452) (6)% (327) (10)% (125) (38)%
Operating (loss) income ​ $(558) (8)% $100 3% $(658) (658)%

nm – not meaningful

Consolidated - As a result of the foregoing, including the integration and reduced profitability at Stadco, we reported an operating loss of $0.6 million compared to operating income of $0.1 million for the three months ended June 30, 2021.

Ranor – Operating income was $0.9 million higher compared to same period prior year, due primarily to significantly improved operating throughput.

Stadco – New project startups and related production activities resulted in unfavorable throughput, and higher unabsorbed overhead that resulted in an operating loss of $1.5 million.

Corporate and unallocated - Corporate expenses were higher for the three months ended June 30, 2022, primarily due to a return to pre-pandemic travel and business activity.

Other (Expense) Income, net

The following table presents other (expense) income for the three months ended June 30:

​ ​ ​ ​ ​ 2022 ​ ​ ​ 2021 ​ ​ ​ $ Change ​ ​ ​ % Change
Other (expense) income, net ​ $(33,225) ​ $10,390 ​ $(43,615) nm ​
Interest expense ​ $(70,246) ​ $(21,054) ​ $(49,192) (234)%
Amortization of debt issue costs ​ $(13,399) ​ $(8,824) ​ $(4,575) (52)%

nm – not meaningful

Interest expense was higher for the three months ended June 30, 2022. The increase in interest expense was due primarily to borrowings under the new Stadco Term Loan and higher amounts borrowed under the revolver loan. We expect to see higher interest expense in fiscal 2023 due to the higher levels of debt incurred since the Stadco acquisition.

Amortization of debt issue costs were higher when compared to the three months ended June 30, 2021. New amortization periods commenced in fiscal 2022 for costs incurred for the Ranor loan extension, and for the new Stadco loan. As a result, we expect to see higher amortization expense in fiscal 2023.

Other expense, net, in the table above, includes an expense accrual for contingent consideration of $33,474 in connection with the Stadco acquisition. Other income for the three months ended June 30, 2021, includes a return of $10,000 for a retainer fee previously paid for outside advisory fees in connection with a class action settlement in March 2021.

Paycheck Protection Program (PPP) Loan Forgiveness

For the three months ended June 30, 2021, as authorized by Section 1106 of the CARES Act, the Small Business Administration remitted to Berkshire Bank, the lender of record, a payment of principal in the amount of $1,317,100, for forgiveness of the Company’s PPP loan. The funds credited to the PPP loan paid this loan off in full.

Income Taxes

For fiscal year 2022 the Company recorded a tax benefit of $173,714, the result of lower taxable income. In fiscal 2021, the Company recorded tax expense of $26,580.

Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences and carryforwards are expected to be recovered or settled. The valuation allowance on deferred tax assets at June 30, 2022 and March 31, 2022 was approximately $2.0 million. We believe that it is more likely than not that the benefit from certain state NOL carryforwards and other deferred tax assets will not be realized. In recognition of this risk, we continue to provide a valuation allowance on these items. In the event future taxable income is below management’s estimates or is generated in tax jurisdictions different than projected, the Company could be required to increase the valuation allowance for deferred tax assets. This would result in an increase in the Company’s effective tax rate.

Net (Loss) Income

As a result of the foregoing, for the three months ended June 30, 2022, we recorded net loss of $0.5 million, or $0.01 per share basic and fully diluted, compared with net income of $1.4 million, or $0.05 per share basic and $0.04 per share fully diluted in fiscal 2021.

Liquidity and Capital Resources

We reported a net loss of $0.5 million for the three months ended June 30, 2022. We reported net a net loss of $0.3 million for the fiscal year ended March 31, 2022. Our liquidity is highly dependent on the availability of financing facilities and our ability to maintain our gross profit and operating income.

As of June 30, 2022, we had $4.5 million in total available liquidity, consisting of $0.6 million in cash and cash equivalents, and $3.9 million in undrawn capacity under our revolver loan. As of March 31, 2022, we had $3.9 million in total available liquidity, consisting of $1.1 million in cash and cash equivalents, and $2.8 million in undrawn capacity under our revolver loan.

On June 16, 2022, Ranor entered into a Third Amendment to Amended and Restated Loan Agreement and Third Amendment to Promissory Note to further extend the maturity date of the Ranor Term Loan to September 16, 2022. The Company has commenced negotiations of a further amended and restated loan agreement with Berkshire Bank, including a potential modification of the loan covenants. We intend to refinance the original term loan made by Berkshire Bank to Ranor in the principal amount of $2.85 million (the “Ranor Term Loan”) by borrowing on terms similar to the current loan and using the proceeds to pay down certain existing debt obligations and lowering our debt levels and debt service requirements. However, there can be no assurance that we will be successful in negotiating for these terms with Berkshire Bank or any other lender.

Our debt financing agreements limit our capital expenditures to $1.5 million annually and contain loan to value, balance sheet leverage, and debt service coverage ratio covenants. At June 30, 2022, the Company was not in compliance with all of these financial covenants.

Berkshire Bank waived the Company’s noncompliance with certain of the financial and related covenants at June 30, 2022. The bank retains the right to act on covenant violations that occur after the date of delivery of the waiver. If the lender had demanded repayment and caused the debt to be considered a short-term obligation, the Company would have been unable to pay the obligation because the Company does not have existing facilities or sufficient cash on hand to satisfy these obligations.

In order for us to continue operations beyond the next twelve months and be able to discharge our liabilities and commitments in the normal course of business, we must secure new long-term financing on terms consistent with our near-term business plans.

We had cash and cash equivalents of $0.6 million and working capital of $2.6 million, a decrease of $0.2 million when compared to March 31, 2022. We believe our available cash, plus cash expected to be provided by operations, Employee Retention Credit cash refunds of approximately $0.9 million, and borrowing capacity available under the revolver loan (until the expiration date of December 20, 2022), will be sufficient to fund our operations, expected capital expenditures, and principal and interest payments under our lease and debt obligations through the next 12 months from the issuance date of our financial statements. Our revolver loan matures in December 2022 and will not be available to provide liquidity unless it is renewed. The Company intends to renew the revolver loan with Berkshire Bank. There was $0.3 million outstanding under the revolver loan at June 30, 2022, and $3.9 million of available liquidity.

The uncertainty associated with the refinancing of the Ranor Term Loan which is due on September 16, 2022, and the Revolver Loan which is due on December 20, 2022, raises substantial doubt about our ability to continue as a going concern.

The condensed consolidated financial statements for the three months ended June 30, 2022, and the consolidated financial statements for the year ended March 31, 2022 were prepared on the basis of a going concern which contemplates that we will be able to realize assets and discharge liabilities in the normal course of business. Accordingly, they do not give effect to adjustments that would be necessary should we be required to liquidate assets. Our ability to satisfy our current liabilities and to continue as a going concern is dependent upon the timely availability of long-term financing and successful execution of our operating plan. The financial statements do not include any adjustments that might result from the outcome of these uncertainties.

The table below presents selected liquidity and capital measures at the period ended:

(dollars in thousands)

​ ​ ​ ​ ​ ​ June 30, 2022 ​ ​ ​ ​ March 31, 2022 ​ ​ ​ ​ Change Amount
Cash and cash equivalents ​ $574 ​ $1,052 ​ $(478)
Working capital ​ $2,646 ​ $2,753 ​ $(107)
Total debt ​ $6,215 ​ $7,356 ​ $(1,141)
Total stockholders’ equity ​ $14,815 ​ $15,264 ​ $(449)

The next table summarizes changes in cash by primary component in the cash flows statements for the three months ended:

(dollars in thousands)

​ ​ ​ ​ ​ ​ June 30, 2022 ​ ​ ​ ​ June 30, 2021 ​ ​ ​ ​ Change Amount
Operating activities ​ $1,448 ​ $137 ​ $1,311
Investing activities ​ (763) ​ (4) ​ (759)
Financing activities ​ (1,164) ​ (27) ​ (1,137)
Net (decrease) increase in cash ​ $(479) ​ $106 ​ $(585)

Operating activities

Apart from our loan facilities, our primary sources of cash are from accounts receivable collections. Our customers make advance payments and progress payments under the terms of each manufacturing contract. Our cash flows can fluctuate significantly from period to period as we mark progress with customer projects and the composition of our receivables collections mix changes between advance payments and customer payments made after shipment of finished goods.

Cash provided by operating activities for the three months ended June 30, 2022 was approximately $1.4 million, as operating cash inflows exceeded outflows as work on new projects commenced and customer cash advances and collections increased. Our fiscal 2023 first quarter was marked by favorable project performance progress and delivery schedules that led to timely customer payments. Cash provided by operations for the three months ended June 30, 2021 was $0.1 million.

Investing activities

We invested approximately $0.8 million in new factory machinery and equipment for the first three months of fiscal 2023. We are limited by our financial debt covenants and may not spend more than $1.5 million for new machinery and equipment in the fiscal year. Purchases of new equipment for the three months ended June 30, 2021 totaled $4,198.

Financing activities

We drew down $1.8 million of proceeds under our revolver loan during the three months ended June 30, 2022 and repaid $2.8 million during the same period. We also used $0.2 million of cash to make periodic lease payments and pay off certain lease and debt obligations. For the three months ended June 30, 2021 we paid down principal of $27,166 on our term debt and finance lease obligations.

All of the above activity resulted in a net decrease in cash of $0.5 million for the three months ended June 30, 2022, compared with a net increase in cash of $0.1 million for the three months ended June 30, 2021.

Berkshire Bank Loans

On August 25, 2021, the Company entered into an amended and restated loan agreement with Berkshire Bank, or the “Loan Agreement”. Under the Loan Agreement, Berkshire Bank continues as lender of the “Ranor Term Loan”, and the revolving line of credit, or the “Revolver Loan”. In addition, Berkshire Bank provided to Stadco a term loan in the original amount of $4.0 million, or the “Stadco Term Loan”. The proceeds of the original Ranor Term Loan of $2.85 million were previously used to refinance existing mortgage debt of Ranor. The proceeds of the Revolver Loan are used for working capital and general corporate purposes of the Company. The proceeds of the Stadco Term Loan were to be used to support the acquisition of Stadco and refinance existing indebtedness of Stadco.

Payments for the original Ranor Term Loan began on January 20, 2017 and are made in 60 monthly installments of $19,260 each, inclusive of interest at a fixed rate of 5.21% per annum, with all outstanding principal and accrued interest due and payable on the maturity date. As amended, the Ranor Term Loan was to mature on June 16, 2022, with a balloon payment of approximately $2.3 million due under the terms of the Loan Agreement with Berkshire Bank. However, on June 16, 2022, Ranor and certain affiliates of the Company entered into a Third Amendment to Amended and Restated Loan Agreement and Third Amendment to Promissory Note to further extend the maturity date of the Ranor Term Loan to September 16, 2022. We expect to commence negotiations of a further amended and restated loan agreement to refinance that debt with Berkshire Bank prior to the new maturity date.

Under the Loan Agreement, Berkshire Bank also makes available to Ranor a revolving line of credit with, following certain modifications, a maximum principal amount available of $5.0 million. The Company drew down $1.8 million under the revolver loan, and repaid $2.8 million of principal during the three months ended June 30. 2022. There was $0.3 million outstanding under the revolver loan at June 30, 2022. Interest-only payments on advances made under the revolver loan during the three months ended June 30, 2022 totaled $1,961 at a weighted average interest rate of 2.75%. Unused borrowing capacity at June 30, 2022 was approximately $3.9 million.

On August 25, 2021, Stadco borrowed $4,000,000 from Berkshire Bank under the Stadco Term Loan. Interest on the Stadco Term Loan is due on unpaid balances beginning on August 25, 2021 at a fixed rate per annum equal to the 7 year Federal Home Loan Bank of Boston Classic Advance Rate plus 2.25%. Since September 25, 2021, and on the 25th day of each month thereafter, Stadco has made and will make monthly payments of principal and interest in the amount of $54,390 each, with all outstanding principal and accrued interest due and payable on August 25, 2028.

Commitments and Contractual Obligations

The following contractual obligations associated with our normal business activities are expected to result in cash payments in future periods, and include the following material items at June 30, 2022:

  • We enter into various commitments with suppliers for the purchase of raw materials and work supplies. In accordance with U.S. GAAP, these purchase obligations are not reflected in the accompanying consolidated balance sheets. Our outstanding unconditional contractual commitments, including for the purchase of raw materials and supplies goods, totaled $6.2 million, all of it due to be paid in fiscal 2023. These purchase commitments are in the normal course of business.
  • Our long-term debt obligations, including fixed and variable-rate debt, totaled $6.2 million, with $3.2 million due over the next twelve months, and approximately $0.6 million due annually for each of the next five years.
  • Our lease obligations, including imputed interest, totaled $7.4 million for buildings and equipment through 2030, with approximately $0.9 million due annually for each of the next eight years.

We believe our available cash, plus cash expected to be provided by operations and borrowing capacity available under the revolver loan (until December 2022 when the Company expects to refinance) and Employee Retention Credit cash refunds will be sufficient to fund our operations, expected capital expenditures, and principal and interest payments under our lease and debt obligations through the next 12 months from the issuance date of the financial statements included in this report.

There are no off-balance sheet arrangements as of June 30, 2022.

EBITDA Non-GAAP Financial Measure

To complement our condensed consolidated statements of operations and comprehensive (loss) income and condensed consolidated statements of cash flows, we use EBITDA, a non-GAAP financial measure. Net (loss) income is the financial measure calculated and presented in accordance with U.S. GAAP that is most directly comparable to EBITDA. We believe EBITDA provides our board of directors, management and investors with a helpful measure for comparing our operating performance with the performance of other companies that have different financing and capital structures or tax rates. We also believe that EBITDA is a measure frequently used by securities analysts, investors and other interested parties in the evaluation of companies in our industry, and is a measure contained in our debt covenants. However, while we consider EBITDA to be an important measure of operating performance, EBITDA and other non-GAAP financial measures have limitations, and investors should not consider them in isolation or as a substitute for analysis of our results as reported under U.S. GAAP.

We define EBITDA as net income plus interest, income taxes, depreciation, and amortization. Net loss was $0.5 million for the three months ended June 30, 2022, as compared to net income of $1.4 million for the three months ended June 30, 2021. The following table provides a reconciliation of EBITDA to net income, the most directly comparable U.S. GAAP measure reported in our condensed consolidated financial statements for the three months ended:

(dollars in thousands)

​ ​ ​ ​ ​ ​ June 30, 2022 ​ ​ ​ ​ June 30, 2021 ​ ​ ​ ​ Change Amount
Net (loss) income ​ $(501) ​ $1,371 ​ $(1,872)
Income tax (benefit) provision ​ (174) ​ 27 ​ (201)
Interest expense (1) ​ 84 ​ 30 ​ 54
Depreciation and amortization ​ 585 ​ 183 ​ 402
EBITDA ​ $(6) ​ $1,611 ​ $(1,617)

(1) Includes amortization of debt issue costs.

Controls and procedures

As filed, 6,285 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Evaluation of Disclosure Controls and Procedures.

Disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) are controls and procedures that are designed to ensure that the information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms and includes controls and procedures designed to ensure that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

As of the end of the period covered by this report, an evaluation was carried out, under the supervision and with the participation of management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of June 30, 2022, our disclosure controls and procedures were not effective due to the material weakness in our internal control over financial reporting described below.

Inherent Limitations over Internal Controls

The Company’s internal control over financial reporting is designed under the supervision of our Chief Executive Officer and Chief Financial Officer, and effected by our board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. GAAP. The Company’s internal control over financial reporting includes those policies and procedures that: (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the Company’s assets; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, and that the Company’s receipts and expenditures are being made only in accordance with authorizations of the Company’s management and directors; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the Company’s assets that could have a material effect on the financial statements.

Management, including the Chief Executive Officer and Chief Financial Officer, does not expect that the Company’s internal controls will prevent or detect all errors and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of internal controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. Also, any evaluation of the effectiveness of controls in future periods is subject to the risk that those internal controls may become inadequate because of changes in business conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Material Weakness

We identified a material weakness in our internal control over financial reporting as of March 31, 2022, which still existed as of June 30, 2022. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis. In connection with the preparation of our financial statements in our Annual Report on Form 10-K, management identified the following material weakness: we did not maintain proper controls, processes and procedures over the initial purchase accounting and the continuing fair value accounting associated with our acquisition of Stadco that were adequately designed, documented and executed to support the accurate and timely reporting of our financial results regarding the initial purchase accounting and the continuing fair value accounting associated with the Stadco acquisition.

Notwithstanding the material weakness, management believes the condensed consolidated financial statements included in this Quarterly Report on Form 10-Q present fairly, in all material respects, the Company’s financial condition, results of operations and cash flows as of and for the periods presented in accordance with U.S. GAAP.

Management’s Remediation Plan

Our management, with the oversight of our audit committee, has initiated steps and plans to take additional measures to remediate the underlying causes of the material weakness, which we currently believe will be primarily through the development and implementation of new procedures, policies, processes, including revising the precision level of management review controls and gaining additional assurance regarding timely completion of our quality control procedures. It is possible that we may determine that additional remediation steps will be necessary in the future.

The material weaknesses will not be considered remediated, however, until the applicable controls operate for a sufficient period of time and management has concluded, through testing, that these controls are operating effectively. We can provide no assurance as to when the remediation of these material weaknesses will be completed to provide for an effective control environment.

Changes in Internal Control over Financial Reporting

For the quarter ended June 30, 2022, there have been no changes in our internal control over financial reporting that have materially affected or are reasonably likely to materially affect, our internal control over financial reporting. The Company continues to evaluate Stadco’s internal controls over financial reporting and integrating such with its own internal controls over financial reporting.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2022-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2022-04-01 to 2022-06-30$7.1mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2022-04-01 to 2022-06-30$6.3mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2022-04-01 to 2022-06-30$817.2kus-gaap:GrossProfit
Selling, general and administrative3 months2022-04-01 to 2022-06-30$1.4mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2022-04-01 to 2022-06-30−$558.0kus-gaap:OperatingIncomeLoss
Interest expense3 months2022-04-01 to 2022-06-30$83.6kus-gaap:InterestExpense
Income tax3 months2022-04-01 to 2022-06-30−$173.7kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2022-04-01 to 2022-06-30−$501.2kus-gaap:NetIncomeLoss
Diluted EPS3 months2022-04-01 to 2022-06-30−$0.01us-gaap:EarningsPerShareDiluted
Basic EPS3 months2022-04-01 to 2022-06-30−$0.01us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2022-04-01 to 2022-06-3034,307,450 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow3 months2022-04-01 to 2022-06-30$1.4mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2022-04-01 to 2022-06-30$204.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2022-06-30$573.6kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2022-06-30$15.5mus-gaap:AssetsCurrent
Total assetsAt period end2022-06-30$37.6mus-gaap:Assets
Current liabilitiesAt period end2022-06-30$12.9mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2022-06-30$22.8mus-gaap:Liabilities
Long-term debtAt period end2022-06-30$3.0mus-gaap:LongTermDebtNoncurrent
Shareholders' equityAt period end2022-06-30$14.8mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001410578-22-002784. Last ingested by Listed: Nov 10, 2026, 04:27 ET. Listed shows no prices and gives no investment advice.